Story

Claude View

The Full Story — A Roll-Up Runs Out of Runway

Nomad Foods began life in 2014 as a Martin Franklin/Noam Gottesman SPAC with one job: buy frozen food brands in Europe, consolidate them, and compound. That thesis delivered for nearly a decade — Iglo (2015), Findus Italy/Nordics (2016), Goodfella's and Aunt Bessie's (2018), Findus Switzerland (2020), Fortenova's Ledo/Frikom (2021) — culminating in nine consecutive years of record net sales and Adjusted EBITDA through 2024. Then in 2025 the story broke. Organic revenue flipped negative, gross margins contracted 210 bps, the Adjusted EPS guide was cut twice, a November refinancing booked a €76m exceptional loss, and in October 2025 the board replaced founding operator CEO Stéfan Descheemaeker with outside hire Dominic Brisby effective January 1, 2026. Management's language has now visibly shifted from "growth-advantaged food company" to "2026 will be a transition year." The roll-up story is over. What replaces it is an internal-turnaround story that investors have not yet seen delivered.

1. The Narrative Arc

For seven years the Nomad story was the same story — find a frozen brand, buy it, integrate it onto the SAP platform, harvest synergies, redeploy cash. The last large acquisition closed in September 2021. Since then the narrative has quietly shifted three times:

1. 2021-2022: from "acquirer" to "operator." The words "platform" and "acquisition pipeline" stayed on the page, but new capital was being spent on buybacks and debt refinancing, not deals.
2. 2023-2024: from "operator" to "reinvestor." Management explicitly told investors they had underfunded brands during the inflation cycle and were now spending to recover volume. The 4Q24 release called Nomad "a growth-advantaged food company."
3. 2025: from "reinvestor" to "turnaround." Every quarter brought a different external reason (Easter timing, weather, UK softness, refi loss) and every quarter the guide moved lower. The October CEO change marks the formal handover of the story.

2. What Management Emphasized — and Then Stopped Emphasizing

Three quiet burials stand out:

• Acquisitions and the "platform" story. In 2021 the 20-F devoted most of its strategy section to acquisition expertise, the founders' track record, and pipeline. By 2025 the language survives verbatim but the only recent example listed is still Fortenova from 2021. Nomad has done no material M&A in five years. The self-description shifted from "Europe's leading frozen foods company" (2021) to "Europe's leading savory frozen food company" (2025) — the market-share denominator became smaller, not larger.
• Green Cuisine / plant-based. Named as an "accelerate" priority in 2021-2022, barely mentioned in 2025 disclosures. The category cooled industry-wide and Nomad stopped talking about it without acknowledging the pivot.
• Russia-fish diversification. A 2022-2023 drumbeat about reducing Russian whitefish exposure, new pangasius contracts from Vietnam, and fishless fish R&D. By 2025 the disclosure shrinks to a single paragraph — partly because it's resolved, partly because it's no longer a talking point.

What replaced them: productivity, cost-out, and shareholder returns. Capital returned to holders climbed from nil dividends pre-2023 to €287M in 2025 (+38% YoY). When a roll-up stops rolling up, this is the playbook.

3. Risk Evolution

• Newly elevated in 2025: weather/climate (explicitly cited as the Q2 2025 volume-decline cause), leverage/refinancing (November 2025 refi booked a €75.9m financing loss), and CEO succession.
• Quietly receding: COVID-19 (now one line), Brexit (gone from talking points), Fortenova integration (closed out).
• Stubbornly persistent: input-cost inflation. Management declared a "once-in-a-generation inflation shock" in 2022-2023, then claimed it was behind them in 2024 — and then 2025 brought "supply chain inflation headwinds" as the #1 gross-margin story again. 350 bps of COGS inflation hit FY25 gross margin, only partly offset by 190 bps of productivity.
• New language to watch: the FY2025 20-F elevates "Failure to adequately address current and emerging sustainability risks" as a cross-referenced risk and highlights Science Based Targets initiative validation — sustainability is becoming a formalized risk pillar rather than a marketing statement.

4. How They Handled Bad News

Nomad's 2025 was a four-act explanation, each act blaming a different external factor. The pattern — a miss attributed to a "transitory" cause every quarter — itself becomes the signal.

The contrast with 2024 is instructive. In 3Q24 management faced a genuine operational miss — the SAP/ERP go-live disrupted service levels and cost an estimated 2.5% of quarterly volume. They disclosed the magnitude precisely, cut guidance once, and delivered the revised numbers. That handling was credible. The 2025 handling — three sequential cuts, each blamed on a different weather-adjacent cause — was not.

5. Guidance Track Record

Credibility score: 5/10. Nomad built a nine-year track record of hitting or beating guidance, which earned a premium of trust through 2024. That credibility was spent in 2025: initial FY25 Adj EPS guide of €1.85-€1.89 landed at €1.66 — a miss of roughly 11% versus the mid-point — after three in-year cuts. The initial FY2026 guide (revenue -2% to -5%, Adj EPS -4% to -13%) is explicitly framed as "transition-year" guidance with a fresh CEO starting. The right read: treat prior-regime guidance as a sunk-cost credit and treat Brisby's first full-year guide as having no baseline. Score improves only if FY26 lands in the upper half of its own range.

6. What the Story Is Now

The current story, stripped of the legacy talking points, is simpler and harder:

1. A de-risked cash machine. Nomad still prints €180-290M of adjusted free cash flow per year, is returning all of it to shareholders (€287M in 2025, nearly 10% of market cap), and has term loans extended to 2032. The refinancing loss was largely non-cash noise; the runway is real.
2. A contracting top line. Organic revenue declined 1.9% in 2025 and is guided down another 2-5% in 2026. Volume has been negative three of four quarters in 2025. The European frozen category is "resilient" per management but growth is not currently flowing to Nomad.
3. An external-hire turnaround under Brisby. Dominic Brisby joined from Flora Food Group. He has no history with the founders' SPAC playbook, has committed to buying shares personally, and has positioned 2026 as a reset year. His track record at Nomad is zero quarters.
4. A buyback-driven EPS story. Share count fell from ~170M (2023) to ~142M (end-2025) — a 16% reduction in two years. This is the primary reason Adjusted EPS has held up better than EBITDA. It is sustainable only while cash flow and the balance sheet support it.

What still looks stretched: goodwill and intangibles of ~€4.6 billion against €2.7B equity — if the turnaround does not resume growth, impairment becomes a multi-year question, especially on the Fortenova and Iglo goodwill stacks. Adjusted EBITDA margin of 17.2% is still industry-competitive but has rolled back to 2021 levels, and A&P investment is now being paid for out of overhead cuts rather than margin expansion.

Bottom line: the roll-up story that worked from 2014 to 2022 is over. The operating story that worked in 2023-2024 has broken. The story now is whether a new CEO can restart organic volume inside a cash-generating but slow-growth European category — with a clock set by the buyback authority and a refi window already extended. It is the right setup for patient value investors and the wrong setup for anyone paying for growth.